Spelling suggestions: "subject:"nfkb"" "subject:"nfrkb""
61 |
Screening for activators of NF-kB using Sleeping Beauty TransposonsDasgupta, Maupali 01 February 2008 (has links)
No description available.
|
62 |
Dissecting the Roles of the Non-canonical NF-kB signaling in the Pathogenesis of Lymphoma and AutoimmunityWang, Zhe 18 June 2008 (has links)
No description available.
|
63 |
Siglec-G Is A Negative Regulator Of Nf-Kb Activation And Has Pivotal Roles In B-1 Cell Development And Resistance To SepsisDing, Cheng 17 November 2008 (has links)
No description available.
|
64 |
Role of cIAP1 and cIAP2 in Skeletal MuscleWhitney, Rachael 25 July 2022 (has links)
The cellular inhibitor of apoptosis 1 and 2 (cIAP1 and cIAP2) proteins are essential regulators of the classical and alternative NF-κB pathways. The NF-κB pathway has been shown to be an important regulator of myogenesis and plays a role in skeletal muscle disease, but the involvement of cIAP1 and cIAP2 has not been examined in healthy skeletal muscle. I sought to characterize skeletal muscle of the cIAP1-null and cIAP2-null mice. We show mice lacking cIAP1 exhibit decreased satellite cell numbers in the TA following cardiotoxin-induced injury and in the uninjured soleus muscle, suggesting cIAP1 may be important for satellite cell expansion. cIAP2 may play a role in fiber maintenance and homeostasis as we show cross- sectional are of cIAP2-null uninjured tibialis anterior fibers at 7 and 10 weeks of age were significantly smaller than wild-type fibers. Furthermore, cIAP1- and cIAP2-null mice subjected to in situ force experiments demonstrated altered twitch kinetics compared to wild-type controls in the soleus and EDL, suggesting fast and slow-twitch fibers are affected differently by loss of cIAP1 and cIAP2. Further work elucidating the downstream mechanisms by which cIAP1 and cIAP2 regulate skeletal muscle development and regeneration will be beneficial to the development of treatments for muscular disorders. In this regard, Smac mimetic compounds (SMCs) are small molecule inhibitors that target cIAP1/2 for degradation, thus provide a potential therapeutic treatment for muscular disorders.
|
65 |
Endogenous Stress Signaling within Human Multicellular Aggregates (Spheroids)Jack, Graham Dillon 03 August 2006 (has links)
A wide variety of adherent mammalian cells can be induced into a reversible state of metabolic arrest (quiescence) by conversion to non-adherent multicellular aggregates. These "spheroids" can be maintained at room temperature under oxygen- and nutrient-deprived conditions for extended periods of time (weeks) as well as converted back to viable proliferating monolayers. Herein it is shown that HEK293 spheroid arrest and recovery requires the co-activation of both NF-kB and JNK, and chemical inhibition of either NF-κB nuclear translocation or JNK phosphorylation leads to cell death. Cytokine profiling within the aggregates during the arrest and recovery process is suggestive that a cyclical cascade was in operation, leading to endogenous cytokine production of TNF-Alpha, IL-1Beta, and IL-8, thereby propagating the cellular stress signal within cells as well as throughout the aggregate.
Cytokines exist <i>in vivo</i> as mixtures, yet tissue culture studies delineating how cells respond to these molecules are often performed using individual effectors added exogenously. Are the results obtained in these studies true representations of physiological responses? As HEK293 multicellular aggregates (spheroids) survive long term arrest by endogenous cytokine (TNF-α and IL-1β) and chemokine (IL-8) signaling, adherent monolayer cells were evaluated for their ability to provide a "spheroid signal response" when exposed to TNF-α, IL-1β and IL-8 individually, and in combination, at concentrations observed in the aggregates. The spheroid signal transduction response was only observed when all three cytokines were present, demonstrating that signal transduction cascade mechanisms are cytokine-profile dependent.
To determine if similar processes were involved in the arrest and recovery of multicellular aggregates derived from other cell types, the responses of primary human foreskin fibroblasts (HFF-2) and a glioblastoma cell line (T98G) were characterized, utilizing the procedures developed in the HEK293 study. Both the T98G and HFF-2 cell lines entered and exited from the long term arrest utilizing an autocrine response. However, while the carcinoma cell line was dependent upon NF-κB for survival, its signaling partner was Gadd45α and signaling occurred through the p38 pathway. Primary fibroblast arrest and recovery proceeded through the p38 pathway as well, but was independent of NF-κB. Thus, three different cell types and transformation states (HEK293, HFF-2, and T98G) provided three different routes to survival, all with cyclical cytokine production and signaling. These routes cannot be measured or modulated effectively in adherent monolayers. Multicellular aggregates provide higher ordered systems that can be used to describe signaling pathways within a cell, highlighting the role of autocrine responses and the synergistic relationships between cytokines and neighboring cells. / Ph. D.
|
66 |
NF-kB Inducing Kinase (NIK) Influences Eosinophil Development, Survival, and PlasticityTrusiano, Briana Lynn 22 April 2024 (has links)
Hypereosinophilic (HES) syndrome is an umbrella term encompassing several disease subsets that affects humans and veterinary species, ultimately resulting in >1,500 eosinophils/uL circulating in the blood documented over six-months. This eventually culminates in end-organ infiltration and increased patient morbidity and mortality. In mice where the gene Map3k14 encoding NF -kB inducing kinase (NIK) is knocked out, a HES-like syndrome develops that is dependent on Th2 cells and cytokines. NIK is the upstream regulator of the noncanonical NF-kB pathway and is involved in lymphoid organ development, B cell lymphopoiesis, and myelopoiesis. In addition to regulating the noncanonical NF-kB pathway, NIK is also involved in regulation of kB dimers of the canonical NF-kB pathway and can function independent of NF-kB signaling by regulating lipid and glucose metabolism, mitochondrial, and RIP1 binding to influence cell survival and death. Despite previous studies performed in the Nik-/- model, the mechanisms underlying eosinophil development, plasticity, and fitness in conjunction with the bone marrow and splenic microenvironments have not been fully elucidated.
In the present work, we reviewed current data exploring the influence of the noncanonical NF-kB pathway and NIK specifically on the development of acute myeloid leukemias (AMLs) and Myelodysplastic Syndrome (MDS) with a focus on how these mechanisms might induce subvariants of HES. We next examined the effect of NIK loss on eosinophilopoiesis within hematopoietic tissues in vivo and in various cell culture environments in vitro via cytology, histology, flow cytometry, FACS, positive cell selection, MTT assay, BrDU assay, and protein microarray analysis. Overall, our findings suggest that NIK influences eosinophil maturation, proliferation, metabolism, survival, and potentially plasticity in vivo and in vitro under different environmental conditions and Th2 cytokine influence. NIK loss was also associated with altered free and bound TNFR1 levels on day 13 in vitro. TNFR1 acts upstream of RIP1 and suggests that these differences may be due to NF-kB independent functions of NIK. Overall, these results provide further insight into the potential mechanisms underlying eosinophilopoiesis in the Nik-/- murine model. This information may prove useful in discovering new treatment options underlying subvariants of HES in both human and veterinary patients. / Doctor of Philosophy / A less well-known albeit important white blood cell (WBC) is the eosinophil. It is essential for combating parasitic infections but is also involved in allergic responses. Hypereosinophilic Syndrome (HES) is an umbrella term encompassing a variety of diseases that affects human and veterinary patients. It results in an overproduction of eosinophils not associated with parasitic infections or allergic responses. Although several variants of the disease exist, diagnosing subsets of HES poses a diagnostic challenge and can impact patient care and prognosis long term.
Mice carrying a genetic deletion (Map3k14) encoding a kinase known as NF-kB inducing kinase (NIK) develop HES-like syndrome; these mice are hereafter referred to as Nik-/- mice. HES-like syndrome in Nik-/- mice develops secondary to NIK loss in Th2 lymphocytes (another type of WBC). NIK is an upstream regulator of the noncanonical NF-kB pathway that influences WBC, lymph node, and spleen development. NIK also regulates canonical NF-kB molecules and can function independent of NF-kB signaling by impacting fat and glucose metabolism, binding to mitochondria, and interacting with a kinase known as RIP1 to regulate cell death or survival. Despite previous work studying HES-like syndrome in Nik-/- mice, the specifics of the bone marrow and eosinophil development in response to Th2 cells have not been fully characterized.
In the present work, we reviewed data exploring the noncanonical NF-kB pathway and NIK specifically in the development of WBC cancers and how this might manifest as HES. We then studied eosinophil development in the bone marrow, spleen and in culture for both Nik-/- and wild-type mice by assessing cell and tissue morphology, cell surface marker expression, response to Th2 signaling molecules, as well as cell maturation, death, metabolism, proliferation, and cytokine production. Our findings suggest that NIK is essential for eosinophil growth and survival. We also noted differences in a molecule known as TNFR1 in Nik-/- cultures on day 13. This molecule acts upstream of RIP1, suggesting an NF-kB independent function of NIK in regulating eosinophil maturation in response to Th2 molecules. This information may prove useful in discovering new treatments for HES in human and veterinary patients.
|
67 |
Dérégulation de l'épissage alternatif lors de l'infection par le virus HTLV-1 : rôle de Tax / Deregulation of alternative splicing during HTLV-1 infection : role of TaxThénoz, Morgan 10 April 2014 (has links)
Le virus T lymphotropique humain HTLV-1 est l’agent étiologique de la leucémie-lymphome T de l’adulte (ATLL) et de nombreuses maladies inflammatoires. HTLV-1 est associée à de nombreuses modifications quantitatives de l’expression des gènes cellulaires. À ce jour, ces modifications ont été décrites essentiellement à l’échelle transcriptionnelle à travers notamment les effets de l’oncoprotéine virale Tax, et plus récemment HBZ. Outre leurs impacts sur les niveaux d’activité des promoteurs, certains facteurs apparaissent jouer également un rôle dans la régulation de l’épissage alternatif. Ce mécanisme essentiel à la diversité du transcriptome et du protéome cellulaire, apparait étroitement couplé à la transcription et ses dérégulations sont de plus en plus décrites dans les phénomènes cytotoxiques et pathogènes tels que les infections et les cancers. Dans ce contexte, mon travail s’est intéressé à caractériser les profils d’expression des exons des cellules T CD4+ infectées ou non, et transformée ou non par HTLV-1 in vivo. Dans une seconde étude, j’ai abordé les aspects mécanistiques des modifications d’épissage alternatif par HTLV-1. Mes données montrent que, outre ses effets sur la régulation quantitative de l’expression des gènes cellulaires, l’activation de la voie NF-kB par l’oncogène Tax est impliquée dans la reprogrammation de l’épissage alternatif de nombreux gènes. Ces données révèlent un nouveau degré de complexité dans les mécanismes de dérégulation de l’expression des gènes cellulaires par HTLV-1 et ouvre de nouvelles perspectives d’investigations dans la compréhension des processus leucémogènes associés à l’infection par le virus HTLV-1 / Reprogramming cellular gene transcription sustains HTLV-1 viral persistence that ultimately leads to the development of adult T-cell leukemia/lymphoma (ATLL). We hypothesized that besides these quantitative transcriptional effects. HTLV-1 quantitatively modifies the pattern of cellular gene expression. Exon expression analysis shows that patients’ untransformed and malignant HTLV-1+ CD4+ T-cells exhibit multiple alternate exon usage (AEU) events. These affect either transcriptionally modified or unmodified genes, culminate in ATLL, and unveil new functional pathways involved in cancer and cell cycle. A total of 486 exon modifications occurred in untransformed infected CD4+ cells were detected in ATLL arguing for a role of AEUs in HTLV-1 leukemogenesis. Unsupervised hierarchical clustering of array data permitted to isolate exon expression patters of 3977 exons that discriminate uninfected, infected, and transformed CD4+ T-cells. Exposing cells to splicing inhibitors revealed that Sudemycin E reduces cell viability of HTLV-1 transformed cells without affecting primary control CD4+ cells and HTLV-1 negative cell lines, suggesting that the huge excess of AEU might provides news targets for treating ATLL. Taken together, these data reveal that HTLV-1 significantly modifies the structure of cellular transcripts and unmask new putative leukemogenic pathways and possible therapeutic targets
|
68 |
Análise da expressão de genes regulados pela proteína Dermicidina nas células do melanoma maligno G-361 pelo método de DNA-microarray / Gene expression analysis regulated by Dermcidin protein in G-361 malignant melanoma cell line by DNA-microarrayperez Sosa, Nancy Marcela 15 August 2014 (has links)
A proteína dermicidina (DCD) é codificada por um gene localizado na porção 12q13 do cromossomo 12, presente apenas em primatas e humanos. A proteína é secretada por células de glândulas da pele, melanócitos, neurônios e células epiteliais da mama normal. Alguns estudos inciais revelaram a participação da proteína DCD em processos oncogênicos nos carcinomas de mama, próstata e melanoma pela sua capacidade de atuar como um fator de crescimento e sobrevivência celular. Nos estudos realizados no nosso laboratório mostramos que a DCD é expressa em células normais da pele, placenta, cérebro e em vários tumores, incluindo os carcinomas de mama e melanoma maligno. Ensaios biológicos e bioquímicos mostraram que o \"knockdown\" da expressão de DCD no melanoma maligno G-361 via RNA de interferência (RNAi) diminuiu significativamente o crescimento in vitro em cultura celular e a formação de tumores em camundongos Nude. Resultados similares foram obtidos quando camundongos Nude transplantados com células de melanoma G-361 foram tratados com anticorpos policlonais de coelhos contra a proteína DCD. Para compreender melhor o papel da proteína DCD na transformação de células de melanoma G-361 foram feitos ensaios de microarranjo de DNA para identificar os genes diferencialmente expressos entre as sublinhagens pLKO (controle) e IBC-I que expressa o shRNA para o mRNA da DCD. Entre os 374 genes alterados pelo silenciamento, encontramos 162 com expressão aumentada e 212 com a expressão reduzida. Os estudos de bioinformática pelo software MetaCore mostraram que o silenciamento do gene DNA modula as vias canônicas e redes de sinalização mediadas pelo receptores e ligantes da família BAFF/APRIL que contralam a ativação do fator de transcrição NF-kB, bem como para histonas envolvidas na remodelação da cromatina. Os níveis de expressão de mRNA de 9 genes de interesse foram validados por ensaios de RT-qPCR. Em uma segunda fase do estudo, foram analisadas as proteínas presentes em extratos nuclares dos clones pLKO e IBC-I de melanoma maligno G-361 por espectrometria de massas. Nos extratos proteicos da sublinhagem pLKO foram identificadas 74 proteínas nucleares, enquanto que na sublinhagem IBC-I foram identificadas 31 proteínas. Um grupo de 21 proteínas foi identificado em ambas sublinhagens. Estudos de bioinformática pelo programa STRING revelou que 14 das proteínas identificadas na sublinagem G-361-pLKO faziam interações diretas ou indiretas com a DCD. A rede formada por estas proteínas tem como centro a proteína p53, uma proteína chave na regulação do programa de morte celular e sobrevivência ao estresse oxidativo. Por outro lado, notou-se que a maioria das proteínas identificadas no extrato nuclear da sublinhagem IBC-I é da família das histonas e que poderiam atuar em complexos de remodelação da cromatina nas células G-361-IBC-I. Nossos resultados nos possibilitaram sugerir que futuros estudos sobre a expressão das histonas e suas modificações pós-traducionais poderão ajudar a desvendar o possível papel da DCD na regulação epigenética do melanoma e em outros tipos de cânceres / Dermcidin (DCD) is a human gene mapped to chromosome 12q13 region, only identified in primates and humans, and normally expressed in the eccrine glands of skin and brain. Several studies have confirmed that DCD-derived peptides contribute to innate and immune surveillance and in the oncogenic processes of breast, prostate and skin cancers, as revealed by its role as a growth factor and cell survival. We have further explored DCD function and its tumorigenic potential on skin melanocytes by specifically knocking down its expression in G-361 malignant melanoma cells via expressing constitutively short hairpin RNA against DCD mRNA. Biological and biochemical assays showed that the \"knockdown\" in the expression of DCD in G-361-pLKO control clone and a G-361-IBC-I clone expressing constitutively short hairpin RNA against DCD mRNA decreased significantly the in vitro growth in cell culture and tumor formation in nude mice. Similar results were obtained treating nude mice bearing G-361 melanoma xenografts with rabbit polyclonal antibodies against DCD protein. Here, we present a DNA microarray-based study that identified the genes that are up- and down-regulated in a G-361-pLKO control clone and a G-361-IBC-I clone expressing constitutively short hairpin RNA against DCD mRNA. A total of 372 genes differentially expressed were identified; being 162 genes up-regulated and 212 genes down-regulated. Bioinformatic studies showed that DCD gene silencing modulates canonical pathways and signaling networks mediated APRIL/BAFF receptors and ligands and NF-kB signaling pathway as well as chromatin remodeling mediated by histone family. The mRNA expression levels of 9 genes of interest were validated by RT-qPCR assays. Next we analyzed the proteins present in nuclear extracts from G-361- pLKO and G-361-IBC-I clones by mass spectrometry. We identified 74 proteins in the G-361-pLKO clone and 31 proteins in the G-361-IBC-I. A group of 21 proteins was identified in both sublineages. Bioinformatics analyses by STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) platform showed that a small portion of the proteins identified only in G-361- pLKO cells was predicted to interact directly with DCD. The network formed by these proteins is centered in the p53 protein, a key regulator of survival and cell death program in response to DNA damage and oxidative stress. On the other hand, this network was completed abrogated using the nuclear protein from G-361-IBC-I because of absence of DCD protein. Since most of the proteins identified in nuclear extracts are of the histone family, it is likely that they are acting in the chromatin-remodeling complexes which are important to remodel nucleosomes of the G-361-IBC-I cells. Our results allowed us to suggest that future studies on the expression of histones and their posttranslational modifications may help to unravel the possible role of DCD in the epigenetic regulation of melanoma and other cancers
|
69 |
Mecanismos envolvidos nos efeitos anti-inflamatório e anti-hipernociceptivo da Isobruceina B / Mechanisms involved in the anti-inflammatory and antihypernociceptive effects of Isobrucein BSilva, Rangel Leal 16 May 2013 (has links)
Objetivo: Avaliar o efeito da Isobruceina B como anti-hipernociceptivo e antiinflamatório, e identificar o mecanismo molecular envolvido. Métodos: Inicialmente, o efeito da IsoB sobre a hipernocicepção inflamatória do tecido plantar foi avaliada por von Frey eletrônico. Os tecidos plantares foram removidos para quantificação indireta da infiltração de neutrófilos por mieloperoxidase (MPO). Seu efeito nocicepção térmica foi avaliado em camundongos pelo teste da placa quente a 55º C. Camundongos pré-tratados com IsoB (s.c.) e tratados com carragenina (i.pl), tiveram seus tecidos plantares removidos para quantificação da liberação de citocinas TNF, IL-1? e KC/CXCL1. Para os estudos in vitro, foram utilizados macrófagos extraídos da cavidade peritoneal de camundongos naïve, pré-tratados com 3% de tioglicolato (i.p.) ou de linhagem RAW 264.7. Macrófagos peritoneais foram incubadas com lipopolissacarídeo (LPS) na presença ou ausência de diferentes concentrações de IsoB, para a quantificação da liberação das citocinas TNF, IL-1?, KC/CXCL1 e IL-10 no sobrenadante pelo método de ELISA. A produção in vitro de óxido nítrico (NO) foi indiretamente determinada pelo método de Griess. Para verificar o efeito da IsoB sobre a via do NF-kB, foram utilizados macrófagos RAW 264.7 estavelmente transfectados com um gene para expressão de luciferase dependente de NF-kB (RAW-Luc), incubados com diferentes estímulos (LPS, peptideoglicano, TNF e acetato de forbol miristato [PMA]) na presença ou ausência de IsoB. A atividade da luciferase foi detectada por meio do Luminômetro. A citotoxicidade da IsoB foi avaliada por MTT, lactato desidrogenase e ensaios de citotoxicidade pelo azul de tripan em macrófagos, in vitro. O efeito da IsoB em macrófagos, sobre a degradação o IkB-? e translocação do NF-kB (pela marcação da subunidade p65) para o núcleo e foram examinados por Western Blot de extratos nucleares e citoplasmáticos, e por Microscopia Confocal. O efeito da IsoB sobre a transcrição do RNAm do gene TNF induzido por LPS, foi avaliada por RT-PCR. Células HEK 293 transfectadas foram utilizadas para verificar o efeito da IsoB sobre a síntese de proteínas. Resultados: A IsoB inibe a hipernocicepção inflamatória, mas não tem efeito sobre a nocicepção térmica. IsoB inibiu a produção/libertação das citocinas IL-1? e KC/CXCL1 in vivo, e de TNF, IL-1?, KC/CXCL1, IL-10 e NO in vitro de forma concentração-dependente. O composto analisado também inibiu a atividade da luciferase, NF-kB dependente, por todos os estímulos testado, de forma concentração-dependente. Não foi detectada atividade citotóxica em nenhuma das concentrações testadas. A IsoB não inibe a degradação do IkB-? ou a translocação de NF-kB para o núcleo. Inesperadamente, o composto natural testado também não reduziu a transcrição de RNAm do gene TNF, porém inibiu a síntese de luciferase inespecificamente induzida. Conclusão: A redução da liberação de citocinas pró- inflamatórias, tais como TNF, IL-1? e KC/CXCL1 e da migração de neutrófilos são mecanismos envolvidos nos efeitos anti-inflamatório e anti-hipernociceptivo da IsoB. Os presentes resultados sugerem um mecanismo molecular baseado na direta inibição da síntese de proteica. / Objective: To evaluate the effect of the Isobruceina B (IsoB) as antihypernociceptive and anti-inflammatory, and identify the molecular mechanism involved. Methods: Initially the effect of IsoB upon inflammatoy hypernociception on plantar tissue was evaluated by electronic von Frey. Plantar tissues were removed for indirect quantification of neutrophil infiltration by myeloperoxidase (MPO). Its effect on thermal nociception in mice was evaluated by the hot plate test at 55 ° C. Mice pretreated with IsoB (s.c.) and treated with carrageenan (i.pl.), their tissues were removed for quantification of plantar release of cytokines TNF, IL-1? and KC/CXCL1. For in vitro studies, macrophages derived from peritoneal cavity of naive mice, pretreated with 3% thioglycolate (i.p.) or line RAW 264.7 were used. Peritoneal macrophages were incubated with lipopolysaccharide (LPS) in the presence or absence of different concentrations of IsoB for the quantification of the release of cytokines TNF, IL-1?, and IL-10 KC/CXCL1 in the supernatant by ELISA. In vitro production of nitric oxide (NO) was indirectly determined by the Griess method. To verify the effect of IsoB on the pathway of NF-kB, RAW 264.7 macrophages stably transfected with a gene to expression NF-kB-dependent luciferase (RAW-Luc) were incubated with different stimuli (LPS, peptidoglycan, TNF and phorbol myristate acetate [PMA]) in the presence or absence of IsoB. The luciferase activity was detected by the Luminometer. The cytotoxicity of IsoB was assessed by the MTT, lactate dehydrogenase and cytotoxicity assays trypan blue on macrophages in vitro. The effect of IsoB on macrophages upon the IkB-? degradation and NF-kB translocation (p65 subunit for marking) to the nucleus were examined by Western blot of nuclear and cytoplasmic extracts, and Confocal Microscopy. The effect of IsoB on the TNF mRNA gene transcription induced by LPS was assessed by RT-PCR. Transfected HEK 293 cells were used to verify the effect of IsoB on the protein synthesis. Results: IsoB inhibits inflammatory hypernociception, but has no effect on thermal nociception. IsoB inhibited the production/release of cytokines IL-1? and KC/CXCL1 in vivo, and TNF, IL-1?, KC/CXCL1, IL-10 and NO in vitro in a concentration-dependent manner. The analyzed compound also inhibited luciferase activity NF-kB-dependent for all stimuli tested in a concentration-dependent manner. Cytotoxic activity was not detected in any of the concentrations tested. The IsoB not inhibit the degradation of IkB-? or translocation of NF-kB to the nucleus. Unexpectedly, the natural compound tested neither reduced transcription of TNF mRNA, but inhibited the synthesis of luciferase induced nonspecifically. Conclusion: The reduction on release of pro-inflammatory cytokines such as TNF, IL-1? and KC/CXCL1 and neutrophil migration are mechanisms involved in anti-inflammatory and anti-hypernociceptive effects of IsoB. The present results suggest a molecular mechanism based on the direct inhibition of protein synthesis.
|
70 |
Atividade quimiopreventiva da tributirina na hepatocarcinogênese em ratos / Chemopreventive activity of tributyrin in hepatocarcinogenesis in ratsKuroiwa-Trzmielina, Joice 29 March 2007 (has links)
No presente estudo avaliou-se a atividade quimiopreventiva da tributirina (T), pró-fármaco do ácido butírico (AB) e presente naturalmente em leite e derivados, quando administrada a ratos Wistar durante as etapas de iniciação e seleção/promoção do modelo de hepatocarcinogênese do \"Hepatócito Resistente\" (RH). Os animais receberam diariamente, durante 8 semanas consecutivas e por entubação gástrica: T (200 mg/100 g de peso corpóreo [p.c.]; grupo TB) ou maltodextrina (300 mg/100 g de p.c.; grupo MD; controle isocalórico). Duas semanas após o início dos tratamentos, os grupos foram submetidos ao modelo do RH. Esse consistiu na aplicação intraperitoneal de uma dose do agente iniciante dietilnitrosamina (DEN, 20 mg/100 g de p.c.), seguida, 2 semanas após, da aplicação de 4 doses consecutivas de 2-acetilaminofluoreno (AAF; 2 mg/100 g de p.c.) e de uma hepatectomia parcial (HP) a 70%, acrescida de 2 doses de AAF (2 mg/100 g de p.c.) 2 e 4 dias após a cirurgia. Decorridas 6 semanas após a iniciação com DEN, os animais foram eutanasiados administrando-se, entretanto, 2 horas antes desse procedimento 5-bromo-2-desoxiuridina (BrdU) (10 mg/100 g de p.c.). De acordo com a análise macroscópica dos fígados, e em comparação ao grupo MD, verificou-se que o grupo TB apresentou menor multiplicidade (p < 0,05) e tamanho (p < 0,05) de lesões pré-neoplásicas (LPN) hepáticas. Em relação à análise morfométrica das LPN hepáticas positivas para a enzima glutationa S-transferase forma placentária (GST-P) totais (persistentes + em remodelação) e também nas LPN hepáticas GST-P positivas persistentes, observou-se que em comparação ao grupo MD, o TB apresentou menor tamanho (p < 0,05) e área do corte ocupada (p < 0,05) por essas lesões. O grupo TB apresentou maior porcentagem (p < 0,05) de LPN hepáticas GST-P positivas em remodelação e maior número (p < 0,05) de corpúsculos apoptóticos (CA) nessas LPN em comparação ao MD. Não houve diferenças (p > 0,05) entre os grupos MD e TB em relação à proliferação celular e aos danos no DNA. De acordo com a imunoistoquímica para p53, o grupo TB apresentou menor porcentagem (p < 0,05) de LPN hepáticas totais e persistentes positivas para a proteína, comparado ao MD. O grupo TB apresentou menor ativação (p < 0,05) do fator nuclear-kB (NF-kB) quando comparado ao MD. O grupo TB tendeu a apresentar maior acetilação de histona H3 resíduo de lisina 9 (H3K9) em relação ao grupo MD. A T apresentou atividade quimiopreventiva promissora quando administrada a ratos Wistar diariamente e durante 8 semanas, abrangendo as etapas de iniciação e seleção/promoção do modelo de hepatocarcinogênese do RH. Inibição de LPN hepáticas GST-P positivas persistentes, indução da remodelação e da apoptose, além de normalização da função de p53, inibição da ativação do NF-kB e indução da acetilação de H3K9 parecem estar envolvidas com as ações anticarcinogênicas da T. / Chemopreventive activity of tributyrin (T), a butyric acid prodrug found in milk and its derivatives, was evaluated during the initial phases of the \"Resistant Hepatocyte\" (RH) model of hepatocarcinogenesis. During 8 consecutive weeks, rats received T (200 mg/100 g body weight; TB group) or maltodextrin (M; 300 mg/100 g body weight; MD group; isocaloric control). Two weeks after the beginning of the treatments, the animals received one dose of diethylnitrosamine (DEN; 20 mg/100 g body weight) for initiation. Two weeks later, the animals received six doses of 2-acetylaminofluorene (AAF, 2 mg/100 g body weight), 4 consecutive doses before partial (2/3) hepatectomy and the remaining, two and four days after surgery. All animals were euthanized 6 weeks after DEN administration. Two hours before euthanasia, rats received 5-bromo-2-desoxiuridina (BrdU) (10 mg/100 g body weight). Multiplicity and area of visible hepatocyte nodules/animal were smaller (p < 0,05) in TB group, compared to MD group. Mean area and % liver section area occupied by total (persistant + remodeling) hepatic placental glutathione S-transferase (GST-P) positive preneoplastic lesions (PNL) and persistant hepatic GST-P positive PNL were smaller (p << 0,05) in TB group, compared to control group. Compared to MD group, TB group presented increased (p < 0,05) % of remodeling hepatic GST-P positive PNL and increased number of apoptotic bodies in these PNL. No differences (p gt; 0,05) were observed between MD and TB groups regarding cell proliferation and DNA damage. TB group presented reduced (p < 0,05) % of total and persistant PNL p53 positive compared to MD group. TB group presented reduced (p < 0,05) nuclear factor-kB (NF-kB) activation in comparison with MD group. Lysine 9 acetylation site in H3 (H3K9) tended to be increased in TB group compared to MD. These results indicate that T represents promising chemopreventive agent against hepatocarcinogenesis when administered to Wistar rats during 8 consecutive weeks on initial phases of RH model. Persistant hepatic GST-P positive PNL inhibition, remodeling and apoptosis induction, p53 function normalization, inhibition of NF-kB activation and H3K9 acetylation can be involved with antineoplastic T actions.
|
Page generated in 0.0183 seconds